Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL PEN NEEDLES MARKET SIZE WAS VALUED AT USD 1.2 BILLION IN 2021 AND IS EXPECTED TO REACH USD 1.7 BILLION BY 2027, GROWING AT A CAGR OF 6.09% FROM 2022 TO 2027
The Global Pen Needles Market Size, Share, Growth Forecast by:
- Product Type: Standard Pen Needles and Safety Pen Needles
- Length: Short Length and Long Length
- Therapy: Insulin and Non-Insulin
- Distribution Channel: Retail and Online
- Geography: Europe, North America, Latin America, APAC, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Share & Forecast 2022–2027
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL PEN NEEDLES MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2021) | USD 1.2 Billion |
| Market Size (2027) | USD 1.7 Billion |
| CAGR (2022-2027) | 6.09% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Product Type, Length, Therapy, and Distribution Channel |
| Geographic Analysis | Europe, North America, Latin America, APAC, and Middle East & Africa |
| Countries Covered | Germany, France, UK, Italy, Spain, US, North America, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia |
MARKET OVERVIEW
The global pen needles market was valued at USD 1.2 billion in 2021 and is expected to reach USD 1.7 billion by 2027, growing at a CAGR of 6.09% from 2022 to 2027. Pen needles are the needles that are attached to the durable or prefilled pens that the patients use to inject the medication. The pen needles are found mainly among insulin users, growth hormone users, and other self-injecting medication users.
The advancements in needle manufacturing technology have resulted in shorter and thinner needles. This has helped the vendors to reduce needle stick injuries. This even made vendors focus on thinner and thinner needles. These thinner needles are more user-friendly, progressively improving patient self-rating of injection comfort. BD (Becton, Dickinson) is one of the key innovative players and launched many revolutionary products in the pen needles segment.
Growth in the market is largely driven by the growing prevalence of the diabetic population and the favorable demand for self-injection devices. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market.
All injector pens require single-use replaceable pen needles for each injection. The companies offer pen needles in various lengths to accommodate varying depths of subcutaneous tissue under the top of the skin. Pen needles are designed for single-use subcutaneous injection of medication and are not intended to be reused for more than one administration. The pen needles are generally manufactured with an outer protective plastic shell, which a person uses to attach the needle to the pen, and an inner plastic shell protecting the needle itself. The doctor or nurse's responsibility instructs how to attach and use needles to ensure proper use properly.
MARKET TRENDS & DRIVERS
The Rising Prevalence of Diabetic Population
Diabetes prevalence in all regions is predicted to rise in the coming years due to unhealthy diets and bad lifestyle choices. The countries are increasingly putting in demand for medication in recent years, majorly the low-income countries, as the patients are more convenient with injector pens. The rising incidences of needle-stick injuries due to the high usage of 8mm syringes and lack of awareness & education in low-middle income countries are also one of the main reasons for the higher adoption of insulin pen needles.
When compared with developed countries, developing countries are more prone to diabetes. In these regions, young children are also affected by diabetes due to childhood obesity, which is a significant risk factor. In the case of developed countries, only older people get affected by diabetes. In contrast, in developing countries, individuals of the adult age and elderly persons above 65 are also prone to diabetes. One in 11 adults in the age group 0-79 is affected with diabetes, especially type-II, which is attributable to lifestyle changes.
Growing Demand for Self-Injection Devices
Devices for self-injection, chiefly pens used for the subcutaneous delivery of biopharmaceuticals, constitute a growing segment of the world of drug delivery devices. With the trend toward biological drugs that cannot be administered orally and the worldwide increase in diabetes, their importance is set to grow further in the future. With the large number of new injectables expected to enter the market in the coming years, the trend to shift treatment from the clinic to the home environment to save costs and provide more patient convenience is increasing the demand for self-injection devices. Self-injection solutions can also significantly improve the quality of care from the patient's perspective. Self-administration by the patient (e.g., using an injection pen) has several advantages. For drugs requiring a subcutaneous application, self-injection pens offer an ideal opportunity to control the time factor and reduce risk.
Technological Advancements in Pen Needles
New pen needles, which are better than the conventional ones, are being introduced to the market. These next-generation pen needles will significantly add an advantage to healthcare providers, nurses, and at-home settings. This trend states that the manufacturers are focusing on improving the traditional portfolios for pen needles. The needle-stick injuries and non-adherence to the therapies are the significant phenomenon in which the manufacturers try to minimize and deliver the medication safely to the patients. There are few manufacturers whose products are top-selling in the market. To reduce risk, those companies have improved their traditional portfolio of pen needles with technology.
Growing Demand for Safety Pen Needles
Accidental blood exposures are caused by contaminated needle sticks, sharps, or splashes and expose HCPs and non-healthcare users to the risk of serious infections. Pen needles with automatic protective safety features allow patients who are temporarily incompetent to continue self-administering drugs with assistance but without compromising healthcare provider (HCP) safety. Moreover, safety pen needles (SPNs) have been found to minimize the risk of exposure to bloodborne infections associated with needle-stick injury without any related adverse events. Safety devices are one of the most effective risk-control measures to prevent healthcare workers' exposure to injuries and infectious agents. Over 80% of NSIs can be prevented with the use of sharps with engineered sharps injury protection system.
SEGMENTATION ANALYSIS
Product Type Analysis
Based on product type, the market is segmented into standard pen needles and safety pen needles. In 2021, standard pen needles held the largest of 71.72% in the global market due to their daily usage of larger doses by diabetic patients. However, these needles are less preferred as they have a higher risk of needle-stick injury and interfere with the safe use of pen needles. Therefore, they are expected to be in low demand soon. Increasing diabetes and awareness of insulin pen use are some factors that support this segment's growth. Safety pen needles are expected to witness favorable growth during the forecast period due to technological advances in this segment and increased launches of next-generation products. These devices make it possible to minimize needle-stick injuries to patients.
Needle Length Analysis
Based on needle length, it is segmented into short needles and long needles. The short needle segment accounted for the largest share of 78.30% in the global market in 2021. Amongst the short needle lengths, 4 mm-sized pen needles are most prescribed to all patients, including obese people suffering from the target disease. Patients are increasingly using the shortest and thinnest needles due to a greater comfort level offered by them as compared to injections. Moreover, their short layer helps reach the subcutaneous tissue of the patients easily.
Therapy Analysis
The market is segmented on therapy into insulin and non-insulin. The insulin pen needles market accounted for the largest share of 81.20% in the global market in 2021 and is also expected to showcase lucrative growth over the forecast period. This is due to the increasing awareness about the self-administration of insulin therapy amongst type 1 and types 2 diabetes patients. In non-insulin therapy, GLP-1 and growth hormone therapy is expected to exhibit significant growth soon. This is due to its capability to minimize the blood glucose level amongst patients who have type 2 diabetes.
Distribution Channel
The global pen needles market is segmented into retail and online based on distribution channels. The retail segment accounted for the largest share of 76.96% in the global pen needles market in 2021. In the retail segment, hospitals and clinics play a major role in distributing pen needles. The retailer pharmacies prefer to collaborate with hospitals and clinics to get a huge profit as the hospitals and clinics are the first points of contact. Online distribution channels are expected to grow drastically in the coming era. The COVID-19 pandemic has opened the doors for online platforms to surge the demand for pen needles in the market.
GEOGRAPHICAL OVERVIEW
The Europe region is dominating the market and accounts for the share of 33.85%, followed by North America with the share of 29.65%, APAC with a share of 24.90%, Latin America with a share of 7.48%, and the Middle East & Africa region accounted for the share of 6.12% in the global market.
VENDOR ANALYSIS
The key companies profiled in the global pen needles market are:
- BD
- Braun Melsungen
- Novo Nordisk
- Owen Mumford
- Ypsomed
These key players have a wide geographic presence in the region such as Europe, North America, and APAC. The market competition is based on quality, quantity, technology, safety, and price and is expected to surge in the coming years. These companies are focusing on launching next-generation products regarding the demand for self-injection devices and safety pen needles. The competition in the market is low as there are only a few key vendors in the market, and the market is not witnessing many mergers and acquisitions.
Strategies adopted by the market vendors
One of the key vendors, B.Braun Melsungen, is launching the second-generation needles, and other vendors are also coming up with safety needles in the market. These are largely adopted among the developed countries in the market. The increasing target population and adoption of advanced technologies like pen needles in Europe make them dominate the market. This is making the vendors focus the product launches across Europe. The major vendors continuously compete for the leading position in the market, with occasional spurts of competition coming from other local vendors.
SNAPSHOT
The global pen needles market was valued at USD 1.2 billion in 2021 and is expected to reach USD 1.7 billion by 2027, growing at a CAGR of 6.09%.
The following factors are likely to contribute to the growth of the global pen needles market are:
- Increasing Patient Population for Chronic Diseases
- Growing Demand for Safety Needles
- Raise In E-Commerce as a Preferred Distribution Channel
The study considers a detailed scenario of the present global pen needles market and its market dynamics for 2022−2027. It covers a detailed overview of several industry growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Key Vendors
- BD
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- B. Braun Melsungen
- Novo Nordisk
- Owen Mumford
- Ypsomed
Other Prominent Vendors
- AdvaCare Pharma
- Business Overview
- Product Offerings
- Allison Medical
- ARKRAY
- GlucoRx
- Hindustan Syringes & Medical Devices
- HTL-STREFA
- IGAKU NEEDLES
- Iyon Medical
- Links Medical Products
- MedExel
- Medivena
- Montméd
- Narang Medical
- Nipro Europe Group Companies
- Promisemed Medical Devices
- SHANGHAI BERPU MEDICAL
- Simple Diagnostics
- Terumo Europe
- Trividia Health
- UltiMed
- Van Heek Medical
- VOGT MEDICAL
Segmentation by Product Type
- Standard Pen Needles
- Safety Pen Needles
Segmentation by Length
- Short Length
- Long Length
Segmentation by Therapy
- Insulin
- Non-Insulin
Segmentation by Distribution Channel
- Retail
- Online
Segmentation by Geography
- Europe
- Germany
- France
- UK
- Italy
- Spain
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
Frequently Asked Questions
HOW BIG IS THE GLOBAL PEN NEEDLE MARKET?
WHAT IS THE GROWTH RATE OF THE GLOBAL PEN NEEDLE MARKET?
WHO ARE THE KEY PLAYERS IN THE GLOBAL PEN NEEDLE MARKET?
WHAT ARE THE GROWTH ENABLERS IN THE GLOBAL PEN NEEDLE MARKET?
WHICH REGION IS EXPECTED TO HOLD THE LARGEST SHARE BY 2027?
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL PEN NEEDLES MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL UNDIAGNOSED DIABETES POPULATION & MARKET SHARE OF PEN NEEDLES (%)
EXHIBIT 4 REGIONAL SHARES IN GLOBAL PEN NEEDLES MARKET
EXHIBIT 5 IMPACT OF SURGE IN DEMAND FOR SELF-INJECTABLE DEVICES
EXHIBIT 6 IMPACT OF TECHNOLOGICAL ADVANCES IN PEN NEEDLES
EXHIBIT 7 IMPACT OF GROWING PREFERENCE FOR BIOSIMILAR DRUGS
EXHIBIT 8 IMPACT OF EXPANDING PATIENT POPULATION FOR CHRONIC DISEASES
EXHIBIT 9 IMPACT OF GROWING DEMAND FOR SAFETY NEEDLES
EXHIBIT 10 GENERIC RISK MATRIX FOR MEDICAL DEVICES INCORPORATING NEEDLES
EXHIBIT 11 IMPACT OF EMERGENCE OF E-COMMERCE AS PREFERRED DISTRIBUTION CHANNEL
EXHIBIT 12 IMPACT OF REUSE OF PEN NEEDLES
EXHIBIT 13 RISKS ASSOCIATED WITH REUSE OF PEN NEEDLES
EXHIBIT 14 IMPACT OF NEEDLE ANXIETY & SAFETY ISSUES ASSOCIATED WITH PEN NEEDLES
EXHIBIT 15 IMPACT OF HIGH GLOBAL PREVALENCE OF UNDIAGNOSED DIABETES
EXHIBIT 16 GLOBAL UNDIAGNOSED DIABETES POPULATION IN 20–79 AGE GROUP (%)
EXHIBIT 17 GLOBAL PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 18 GLOBAL PEN NEEDLES MARKET SHARE BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 19 GLOBAL PEN NEEDLES MARKET SHARE BY PRODUCT TYPE 2021 & 2027 (%)
EXHIBIT 20 GLOBAL PEN NEEDLES MARKET SHARE BY LENGTH 2021 & 2027 (%)
EXHIBIT 21 GLOBAL PEN NEEDLES MARKET SHARE BY THERAPY 2021 & 2027 (%)
EXHIBIT 22 GLOBAL PEN NEEDLES MARKET SHARE BY DISTRIBUTION CHANNEL 2021 & 2027 (%)
EXHIBIT 23 FIVE FORCES ANALYSIS 2021
EXHIBIT 24 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 25 GLOBAL PEN NEEDLES MARKET BY PRODUCT TYPE
EXHIBIT 26 GLOBAL PEN NEEDLES MARKET BY PRODUCT TYPE: OVERVIEW
EXHIBIT 27 GLOBAL PEN NEEDLES MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH
EXHIBIT 28 GLOBAL PEN NEEDLES MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL PEN NEEDLES MARKET BY STANDARD PEN NEEDLES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 GLOBAL PEN NEEDLES MARKET BY STANDARD PEN NEEDLES 2021–2027 ($ MILLION)
EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 32 PERCENTAGE OF NURSES AFFECTED BY NEEDLESTICK INJURIES WHILE ADMINISTERING INSULIN INJECTIONS
EXHIBIT 33 GLOBAL PEN NEEDLES MARKET BY SAFETY PEN NEEDLES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL PEN NEEDLES MARKET BY SAFETY PEN NEEDLES 2021–2027 ($ MILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 36 INCREMENTAL GROWTH BY LENGTH 2021 & 2027
EXHIBIT 37 GLOBAL PEN NEEDLES MARKET BY LENGTH
EXHIBIT 38 GLOBAL PEN NEEDLES MARKET BY LENGTH: OVERVIEW
EXHIBIT 39 GLOBAL PEN NEEDLES MARKET BY LENGTH: INCREMENTAL GROWTH
EXHIBIT 40 GLOBAL PEN NEEDLES MARKET BY LENGTH: ABSOLUTE GROWTH
EXHIBIT 41 BENEFITS OF SHORT PEN NEEDLES
EXHIBIT 42 GLOBAL PEN NEEDLES MARKET BY SHORT NEEDLES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL PEN NEEDLES MARKET BY SHORT NEEDLES 2021–2027 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 45 GLOBAL PEN NEEDLES MARKET BY LONG NEEDLES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL PEN NEEDLES MARKET BY LONG NEEDLES 2021–2027 ($ MILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 48 INCREMENTAL GROWTH BY THERAPY 2021 & 2027
EXHIBIT 49 GLOBAL PEN NEEDLES MARKET BY THERAPY
EXHIBIT 50 GLOBAL PEN NEEDLES MARKET BY THERAPY: OVERVIEW
EXHIBIT 51 GLOBAL PEN NEEDLES MARKET BY THERAPY: INCREMENTAL GROWTH
EXHIBIT 52 GLOBAL PEN NEEDLES MARKET BY THERAPY: ABSOLUTE GROWTH
EXHIBIT 53 GLOBAL PEN NEEDLES MARKET BY INSULIN THERAPY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL PEN NEEDLES MARKET BY INSULIN THERAPY 2021–2027 ($ MILLION)
EXHIBIT 55 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 56 GLOBAL PEN NEEDLES MARKET BY NON-INSULIN THERAPY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL PEN NEEDLES MARKET BY NON-INSULIN THERAPY 2021–2027 ($ MILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 59 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 60 GLOBAL PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL
EXHIBIT 61 GLOBAL PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL: OVERVIEW
EXHIBIT 62 GLOBAL PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH
EXHIBIT 63 GLOBAL PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL PEN NEEDLES MARKET BY RETAIL: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL PEN NEEDLES MARKET BY RETAIL 2021–2027 ($ MILLION)
EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 67 GLOBAL PEN NEEDLES MARKET BY ONLINE SEGMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL PEN NEEDLES MARKET BY ONLINE SEGMENT 2021–2027 ($ MILLION)
EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 70 GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY
EXHIBIT 71 GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY 2019–2025 ($ MILLION)
EXHIBIT 72 GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 73 GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 74 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 75 EUROPE PEN NEEDLES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 EUROPE PEN NEEDLES MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 77 EUROPE PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY LENGTH 2021 & 2027
EXHIBIT 80 INCREMENTAL GROWTH BY THERAPY 2021 & 2027
EXHIBIT 81 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 82 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 83 GERMANY PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 84 FRANCE PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 85 UK PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 86 ITALY PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 87 SPAIN PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 88 NORTH AMERICA PEN NEEDLES MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 89 NORTH AMERICA PEN NEEDLES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 90 NORTH AMERICA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 91 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 92 INCREMENTAL GROWTH BY LENGTH 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH BY THERAPY 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 96 US PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 97 CANADA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 98 APAC PEN NEEDLES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 APAC PEN NEEDLES MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 100 APAC PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 101 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH BY LENGTH 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY THERAPY 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 105 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 106 CHINA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 107 JAPAN PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 INDIA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 109 SOUTH KOREA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 110 AUSTRALIA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 111 LATIN AMERICA PEN NEEDLES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 112 LATIN AMERICA PEN NEEDLES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 113 LATIN AMERICA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 114 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 115 INCREMENTAL GROWTH BY LENGTH 2021 & 2027
EXHIBIT 116 INCREMENTAL GROWTH BY THERAPY 2021 & 2027
EXHIBIT 117 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 118 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 119 BRAZIL PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 120 MEXICO PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 121 ARGENTINA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 122 MIDDLE EAST & AFRICA PEN NEEDLES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 123 MIDDLE EAST & AFRICA PEN NEEDLES MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 124 MIDDLE EAST & AFRICA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 125 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 126 INCREMENTAL GROWTH BY LENGTH 2021 & 2027
EXHIBIT 127 INCREMENTAL GROWTH BY THERAPY 2021 & 2027
EXHIBIT 128 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 129 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 130 TURKEY PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 131 SOUTH AFRICA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 132 SAUDI ARABIA PEN NEEDLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 133 PURE & DIVERSIFIED VENDORS IN GLOBAL PEN NEEDLES MARKET
EXHIBIT 134 VENDORS OFFERING COMMERCIAL PEN NEEDLES: MARKET DOMINANCE ANALYSIS
EXHIBIT 135 VENDORS OFFERING COMMERCIAL PEN NEEDLES: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 136 BD: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 137 BD: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 138 BD: REVENUE BY BUSINESS SEGMENT 2021 ($ MILLION)
EXHIBIT 139 BD: REVENUE BY GEOGRAPHY 2020–2021 ($ MILLION)
EXHIBIT 140 B. BRAUN MELSUNGEN: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 141 B. BRAUN MELSUNGEN: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 142 B. BRAUN MELSUNGEN: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 143 NOVO NORDISK: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 144 NOVO NORDISK: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 145 NOVO NORDISK: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 146 YPSOMED: TOTAL REVENUE 2020–2022 ($ MILLION)
EXHIBIT 147 YPSOMED: REVENUE BY BUSINESS SEGMENT 2022 ($ MILLION)
EXHIBIT 148 YPSOMED: REVENUE BY GEOGRAPHY 2020–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 SUMMARY OF CROSS-COUNTRY ANALYSIS
TABLE 4 NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES PER WORLD BANK INCOME CLASSIFICATION IN 2021 AND 2045
TABLE 5 EXAMPLES OF SAFETY PEN NEEDLES & THEIR FEATURES
TABLE 6 GLOBAL PEN NEEDLES MARKET BY STANDARD PEN NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 7 GLOBAL PEN NEEDLES MARKET BY STANDARD PEN NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 8 GLOBAL PEN NEEDLES MARKET BY SAFETY PEN NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 9 GLOBAL PEN NEEDLES MARKET BY SAFETY PEN NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 10 GLOBAL PEN NEEDLES MARKET BY SHORT NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 11 GLOBAL PEN NEEDLES MARKET BY SHORT NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 12 GLOBAL PEN NEEDLES MARKET BY LONG NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 13 GLOBAL PEN NEEDLES MARKET BY LONG NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 14 ESTIMATED NUMBER OF DIABETIC ADULTS IN TOP 10 COUNTRIES (20–79 AGE GROUP) 2021 & 2045
TABLE 15 GLOBAL PEN NEEDLES MARKET BY INSULIN THERAPY 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 16 GLOBAL PEN NEEDLES MARKET BY INSULIN THERAPY 2021–2027 (%) (GEOGRAPHY)
TABLE 17 GLOBAL PEN NEEDLES MARKET BY NON-INSULIN THERAPY 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 18 GLOBAL PEN NEEDLES MARKET BY NON-INSULIN THERAPY 2021–2027 (%) (GEOGRAPHY)
TABLE 19 GLOBAL PEN NEEDLES MARKET BY RETAIL SEGMENT 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 20 GLOBAL PEN NEEDLES MARKET BY RETAIL SEGMENT 2021–2027 (%) (GEOGRAPHY)
TABLE 21 GLOBAL PEN NEEDLES MARKET BY ONLINE SEGMENT 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 22 GLOBAL PEN NEEDLES MARKET BY ONLINE SEGMENT 2021–2027 (%) (GEOGRAPHY)
TABLE 23 EUROPE PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 24 EUROPE PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 25 EUROPE PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 26 EUROPE PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 27 EUROPE PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 28 EUROPE PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 29 EUROPE PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 30 EUROPE PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 31 NORTH AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 32 NORTH AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 33 NORTH AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 34 NORTH AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 35 NORTH AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 36 NORTH AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 37 NORTH AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 38 NORTH AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 39 APAC PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 40 APAC PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 41 APAC PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 42 APAC PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 43 APAC PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 44 APAC PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 45 APAC PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 46 APAC PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 47 LATIN AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 48 LATIN AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 49 LATIN AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 50 LATIN AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 51 LATIN AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 52 LATIN AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 53 LATIN AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 54 LATIN AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 55 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 56 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 57 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 58 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 59 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 60 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 61 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 62 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 63 BD: MAJOR PRODUCT OFFERINGS
TABLE 64 B. BRAUN MELSUNGEN: MAJOR PRODUCT OFFERINGS
TABLE 65 NOVO NORDISK: MAJOR PRODUCT OFFERINGS
TABLE 66 OWEN MUMFORD: MAJOR PRODUCT OFFERINGS
TABLE 67 YPSOMED: MAJOR PRODUCT OFFERINGS
TABLE 68 ADVACARE PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 69 ALLISON MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 70 ARKRAY: MAJOR PRODUCT OFFERINGS
TABLE 71 GLUCORX: MAJOR PRODUCT OFFERINGS
TABLE 72 HINDUSTAN SYRINGES & MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS
TABLE 73 HTL-STREFA: MAJOR PRODUCT OFFERINGS
TABLE 74 IGAKU NEEDLES: MAJOR PRODUCT OFFERINGS
TABLE 75 IYON MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 76 LINKS MEDICAL PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 77 MEDEXEL: MAJOR PRODUCT OFFERINGS
TABLE 78 MEDIVENA: MAJOR PRODUCT OFFERINGS
TABLE 79 MONTMÉD: MAJOR PRODUCT OFFERINGS
TABLE 80 NARANG MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 81 NIPRO EUROPE GROUP COMPANIES: MAJOR PRODUCT OFFERINGS
TABLE 82 PROMISEMED MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS
TABLE 83 SHANGHAI BERPU MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 84 SIMPLE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 85 TERUMO EUROPE: MAJOR PRODUCT OFFERINGS
TABLE 86 TRIVIDIA HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 87 ULTIMED: MAJOR PRODUCT OFFERINGS
TABLE 88 VAN HEEK MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 89 VOGT MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 90 GLOBAL PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 91 GLOBAL PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 92 EUROPE PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 93 EUROPE PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 94 NORTH AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 95 NORTH AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 96 APAC PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 97 APAC PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 98 LATIN AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 99 LATIN AMERICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 100 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 101 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 102 GLOBAL PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 103 GLOBAL PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 104 EUROPE PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 105 EUROPE PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 106 NORTH AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 107 NORTH AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 108 APAC PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 109 APAC PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 110 LATIN AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 111 LATIN AMERICA PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 112 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY LENGTH 2021–2027 ($ MILLION)
TABLE 113 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY LENGTH 2021–2027 (%)
TABLE 114 GLOBAL PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 115 GLOBAL PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 116 EUROPE PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 117 EUROPE PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 118 NORTH AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 119 NORTH AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 120 APAC PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 121 APAC PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 122 LATIN AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 123 LATIN AMERICA PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 124 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY THERAPY 2021–2027 ($ MILLION)
TABLE 125 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY THERAPY 2021–2027 (%)
TABLE 126 EUROPE PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 127 EUROPE PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 128 EUROPE PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 129 EUROPE PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 130 NORTH AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 131 NORTH AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 132 APAC PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 133 APAC PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 134 LATIN AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 135 LATIN AMERICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 136 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 137 MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 138 GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 139 GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 140 GLOBAL PEN NEEDLES MARKET BY STANDARD PEN NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 141 GLOBAL PEN NEEDLES MARKET BY STANDARD PEN NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 142 GLOBAL PEN NEEDLES MARKET BY SAFETY PEN NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 143 GLOBAL PEN NEEDLES MARKET BY SAFETY PEN NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 144 GLOBAL PEN NEEDLES MARKET BY SHORT NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 145 GLOBAL PEN NEEDLES MARKET BY SHORT NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 146 GLOBAL PEN NEEDLES MARKET BY LONG NEEDLES 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 147 GLOBAL PEN NEEDLES MARKET BY LONG NEEDLES 2021–2027 (%) (GEOGRAPHY)
TABLE 148 GLOBAL PEN NEEDLES MARKET BY INSULIN SEGMENT 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 149 GLOBAL PEN NEEDLES MARKET BY INSULIN SEGMENT 2021–2027 (%) (GEOGRAPHY)
TABLE 150 GLOBAL PEN NEEDLES MARKET BY NON-INSULIN SEGMENT 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 151 GLOBAL PEN NEEDLES MARKET BY NON-INSULIN SEGMENT 2021–2027 (%) (GEOGRAPHY)
TABLE 152 GLOBAL PEN NEEDLES MARKET BY RETAIL SEGMENT 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 153 GLOBAL PEN NEEDLES MARKET BY RETAIL SEGMENT 2021–2027 (%) (GEOGRAPHY)
TABLE 154 GLOBAL PEN NEEDLES MARKET BY ONLINE SEGMENT 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 155 GLOBAL PEN NEEDLES MARKET BY ONLINE SEGMENT 2021–2027 (%) (GEOGRAPHY)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT TYPE
4.3.2 MARKET SEGMENTATION BY LENGTH
4.3.3 MARKET SEGMENTATION BY THERAPY
4.3.4 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
7.1.1 RISING PREVALENCE OF DIABETES
7.1.2 GROWING DEMAND FOR SELF-INJECTION DEVICES
7.1.3 TECHNOLOGICAL ADVANCES IN PEN NEEDLES
7.1.4 GROWING DEMAND FOR SAFETY PEN NEEDLES
7.1.5 PRODUCT TYPE ANALYSIS
7.1.6 NEEDLE LENGTH ANALYSIS
7.1.7 THERAPY ANALYSIS
7.1.8 DISTRIBUTION CHANNEL
7.1.9 GEOGRAPHY ANALYSIS
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 SURGE IN DEMAND FOR SELF-INJECTABLE DEVICES
9.2 TECHNOLOGICAL ADVANCES IN PEN NEEDLES
9.3 GROWING PREFERENCE FOR BIOSIMILAR DRUGS
10 MARKET GROWTH ENABLERS
10.1 EXPANDING PATIENT POPULATION FOR CHRONIC DISEASES
10.2 GROWING DEMAND FOR SAFETY NEEDLES
10.3 EMERGENCE OF E-COMMERCE AS PREFERRED DISTRIBUTION CHANNEL
11 MARKET RESTRAINTS
11.1 REUSE OF PEN NEEDLES
11.2 NEEDLE ANXIETY & SAFETY ISSUES ASSOCIATED WITH PEN NEEDLES
11.3 HIGH GLOBAL PREVALENCE OF UNDIAGNOSED DIABETES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 GEOGRAPHY ANALYSIS
12.2.2 PRODUCT TYPE ANALYSIS
12.2.3 LENGTH ANALYSIS
12.2.4 THERAPY ANALYSIS
12.2.5 DISTRIBUTION CHANNEL ANALYSIS
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 STANDARD PEN NEEDLES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 STANDARD PEN NEEDLES SEGMENTATION BY GEOGRAPHY
13.4 SAFETY PEN NEEDLES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 SAFETY PEN NEEDLES SEGMENTATION BY GEOGRAPHY
14 LENGTH
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 SHORT NEEDLES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 SHORT NEEDLES SEGMENTATION BY GEOGRAPHY
14.4 LONG NEEDLES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 LONG NEEDLES SEGMENTATION BY GEOGRAPHY
15 THERAPY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 INSULIN
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 INSULIN SEGMENTATION BY GEOGRAPHY
15.4 NON-INSULIN
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 NON-INSULIN SEGMENTATION BY GEOGRAPHY
16 DISTRIBUTION CHANNEL
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 RETAIL
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 RETAIL SEGMENTATION BY GEOGRAPHY
16.4 ONLINE
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 ONLINE SEGMENTATION BY GEOGRAPHY
17 GEOGRAPHY
17.1 GEOGRAPHIC OVERVIEW
17.2 MARKET SNAPSHOT & GROWTH ENGINE
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 EUROPE: PRODUCT TYPE SEGMENTATION
18.2.2 EUROPE: LENGTH SEGMENTATION
18.2.3 EUROPE: THERAPY SEGMENTATION
18.2.4 EUROPE: DISTRIBUTION CHANNEL SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 GERMANY: MARKET SIZE & FORECAST
18.3.2 FRANCE: MARKET SIZE & FORECAST
18.3.3 UK: MARKET SIZE & FORECAST
18.3.4 ITALY: MARKET SIZE & FORECAST
18.3.5 SPAIN: MARKET SIZE & FORECAST
19 NORTH AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 NORTH AMERICA: PRODUCT TYPE SEGMENTATION
19.2.2 NORTH AMERICA: LENGTH SEGMENTATION
19.2.3 NORTH AMERICA: THERAPY SEGMENTATION
19.2.4 NORTH AMERICA: DISTRIBUTION CHANNEL SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 US: MARKET SIZE & FORECAST
19.3.2 CANADA: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 APAC: PRODUCT TYPE SEGMENTATION
20.2.2 APAC: LENGTH SEGMENTATION
20.2.3 APAC: THERAPY SEGMENTATION
20.2.4 APAC: DISTRIBUTION CHANNEL SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 CHINA: MARKET SIZE & FORECAST
20.3.2 JAPAN: MARKET SIZE & FORECAST
20.3.3 INDIA: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA: PRODUCT TYPE SEGMENTATION
21.2.2 LATIN AMERICA: LENGTH SEGMENTATION
21.2.3 LATIN AMERICA: THERAPY SEGMENTATION
21.2.4 LATIN AMERICA: DISTRIBUTION CHANNEL SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA: PRODUCT TYPE SEGMENTATION
22.2.2 MIDDLE EAST & AFRICA: LENGTH SEGMENTATION
22.2.3 MIDDLE EAST & AFRICA: THERAPY SEGMENTATION
22.2.4 MIDDLE EAST & AFRICA: DISTRIBUTION CHANNEL SEGMENTATION
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
22.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 BD
23.2.2 B. BRAUN MELSUNGEN
23.2.3 NOVO NORDISK
23.2.4 OWEN MUMFORD
23.2.5 YPSOMED
24 KEY COMPANY PROFILES
24.1 BD
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 B. BRAUN MELSUNGEN
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 NOVO NORDISK
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 OWEN MUMFORD
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 YPSOMED
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ADVACARE PHARMA
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ALLISON MEDICAL
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 ARKRAY
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 GLUCORX
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 HINDUSTAN SYRINGES & MEDICAL DEVICES
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 HTL-STREFA
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 IGAKU NEEDLES
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 IYON MEDICAL
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 LINKS MEDICAL PRODUCTS
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 MEDEXEL
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 MEDIVENA
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 MONTMÉD
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 NARANG MEDICAL
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 NIPRO EUROPE GROUP COMPANIES
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 PROMISEMED MEDICAL DEVICES
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 SHANGHAI BERPU MEDICAL
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 SIMPLE DIAGNOSTICS
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 TERUMO EUROPE
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 TRIVIDIA HEALTH
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 ULTIMED
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 VAN HEEK MEDICAL
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 VOGT MEDICAL
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY PRODUCT TYPE
26.1.1 EUROPE: PRODUCT TYPE SEGMENTATION
26.1.2 NORTH AMERICA: PRODUCT TYPE SEGMENTATION
26.1.3 APAC: PRODUCT TYPE SEGMENTATION
26.1.4 LATIN AMERICA: PRODUCT TYPE SEGMENTATION
26.1.5 MIDDLE EAST & AFRICA: PRODUCT TYPE SEGMENTATION
26.2 MARKET BY LENGTH
26.2.1 EUROPE: LENGTH SEGMENTATION
26.2.2 NORTH AMERICA: LENGTH SEGMENTATION
26.2.3 APAC: LENGTH SEGMENTATION
26.2.4 LATIN AMERICA: LENGTH SEGMENTATION
26.2.5 MIDDLE EAST & AFRICA: LENGTH SEGMENTATION
26.3 MARKET BY THERAPY
26.3.1 EUROPE: THERAPY SEGMENTATION
26.3.2 NORTH AMERICA: THERAPY SEGMENTATION
26.3.3 APAC: THERAPY SEGMENTATION
26.3.4 LATIN AMERICA: THERAPY SEGMENTATION
26.3.5 MIDDLE EAST & AFRICA: THERAPY SEGMENTATION
26.4 MARKET BY DISTRIBUTION CHANNEL
26.4.1 EUROPE: DISTRIBUTION CHANNEL SEGMENTATION
26.4.2 NORTH AMERICA: DISTRIBUTION CHANNEL SEGMENTATION
26.4.3 APAC: DISTRIBUTION CHANNEL SEGMENTATION
26.4.4 LATIN AMERICA: DISTRIBUTION CHANNEL SEGMENTATION
26.4.5 MIDDLE EAST & AFRICA: DISTRIBUTION CHANNEL SEGMENTATION
26.5 MARKET BY GEOGRAPHY
26.5.1 STANDARD PEN NEEDLES SEGMENTATION BY GEOGRAPHY
26.5.2 SAFETY PEN NEEDLES SEGMENTATION BY GEOGRAPHY
26.5.3 SHORT NEEDLES SEGMENTATION BY GEOGRAPHY
26.5.4 LONG NEEDLES SEGMENTATION BY GEOGRAPHY
26.5.5 INSULIN SEGMENTATION BY GEOGRAPHY
26.5.6 NON-INSULIN SEGMENTATION BY GEOGRAPHY
26.5.7 RETAIL SEGMENTATION BY GEOGRAPHY
26.5.8 ONLINE SEGMENTATION BY GEOGRAPHY
27 REPORT SUMMARY
27.1 KEY TAKEAWAYS
27.2 STRATEGIC RECOMMENDATIONS
28 APPENDIX
28.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
HOW BIG IS THE GLOBAL PEN NEEDLE MARKET?
WHAT IS THE GROWTH RATE OF THE GLOBAL PEN NEEDLE MARKET?
WHO ARE THE KEY PLAYERS IN THE GLOBAL PEN NEEDLE MARKET?
WHAT ARE THE GROWTH ENABLERS IN THE GLOBAL PEN NEEDLE MARKET?
WHICH REGION IS EXPECTED TO HOLD THE LARGEST SHARE BY 2027?
Other RELATED Reports
IV Catheters, Needles, and Syringes Market - Global Outlook and Forecast 2018-2023
Published : July 2018
Digital Diabetes Management Market - Global Outlook and Forecast 2019-2024
Published : November 2019
